A new protocol reduces median door-to-needle time to the benchmark of 30 minutes in acute stroke treatment A.M. Iglesias Mohedano; A. García Pastor; F. Díaz Otero; P. Vázquez Alen; M.A. Martín Gómez; P. Simón Campo; P. Salgado Cámara; E. Esteban de Antonio; E. Lázaro García; C. Funes Molina; M. del Valle Diéguez; J. Saura Lorente; Y. Fernández Bullido; A. Gil Nuñez;

The influence of organisational management on door-to-needle times for fibrinolytic treatment M. Vicente-Pascual; A. Quilez; M.P. Gil; C. González-Mingot; D. Vázquez-Justes; G. Mauri-Capdevila; J. Sanahuja; C. García-Vázquez; F. Purroy;

Controversies in cerebrovascular disease: high or low doses of recombinant tissue plasminogen activator to treat acute stroke? A literature review V. Montalván Ayala; Z. Rojas Cheje; R. Aldave Salazar;